Technologies Available for Licensing
Closure Device which Stores and Can Introduce
an Additive into a container
New Light Capital LLC. has acquired the rights for the allowed patent relating to a closure device that stores and can introduce an additive into a container. New Light Capital has retained Inavisis, Inc. as the exclusive licensing and commercialization group to bring the technology to market.
The allowed patent describes an electrically - actuated valve in a closure device to reduce the complexity of manufacturing, assembly and use.
The technology is designed to preserve active ingredients that might decompose upon exposure to light or air. Then dispense the active
concentrate into a reservoir right before use.
The product could be used in multiple market applications:
- Beverages such as ice coffee and tea.
- Pharmaceutical active ingredients.
- Unstable dyes and colorant.
The technology is at early stage of development and New Light Capital LLC is seeking partners that would be interested in developing the technology and manage the commercial launch of the product in multiple market applications.
Contact Person:
For additional information and detailed deal memorandum please contact Dr. Sam Khoury using the contact tab.
Infraorbital discoloration: Dark Circles
Patented Technology available for Sale or Licensing
Patented Technology available for Sale or Licensing
Dr. Cynthia A. Boxrud MD is the inventor of products that have the ability to change the structure and function
of the skin under the eye eliminating the Dark Circles appearance.
Inavisis, Inc. is the exclusive licensing group retained to license this technology to companies in the industry.
Dr. Boxrud has commercialized the technology under the trademark Eyetopia® system.
Eyetopia® System includes the following products:
The intellectual properties available for licensing include:
For additional information and detailed deal memorandum please contact Dr. Sam Khoury using the contact tab.
Eyetopia® Cream reduced Dark Circles and Swelling under the eyes
of the skin under the eye eliminating the Dark Circles appearance.
Inavisis, Inc. is the exclusive licensing group retained to license this technology to companies in the industry.
Dr. Boxrud has commercialized the technology under the trademark Eyetopia® system.
Eyetopia® System includes the following products:
- Eyelight for serious Dark Circles
- Dark Circle Minimizing Cream
- Hydrating Eye Lift Cream
- Moisturizing Eye Cleanser
The intellectual properties available for licensing include:
- Issued US patent # 7,288,263 “COMPOSITION AND METHOS FOR TREATMENT OF SKIN DISCOLORATION”.
- International filing of the patent WO2006031555 A3
- EYETOPIA registered trademark.
- Formulations trade secret to produce finished products.
- Available Domain Names: www.eyetopiaproducts.com and www.darkcircles.com.
- Products were sold on the QVC Network.
- Licensees will have immediate access to a fully commercialized product line that is
proven effective for treating serious dark circles under the eye. - Dr. Cynthia A. Boxrud, a leading expert in the field of dark circle treatment, developed
and tested the product line. - Licensees will have the opportunity to expand their current product line.
For additional information and detailed deal memorandum please contact Dr. Sam Khoury using the contact tab.
Eyetopia® Cream reduced Dark Circles and Swelling under the eyes
ESTABLISHED HYDROGEN CHLORIDE TECHNOLOGY FOR
THE MANUFACTURING OF TITANIUM DIOXIDE
THE MANUFACTURING OF TITANIUM DIOXIDE
WhiteRock Pigments (WRP) has optimized the process for producing highest product quality of titanium dioxide from ilmenite ore. Inavisis, Inc. is the exclusive licensing group retained to license this technology to companies in the industry.
The technology has been demonstrated at a commercial scale.
Titanium dioxide produced by the WRP technology has the following advantages:
The intellectual properties available for licensing include:
The technology has been demonstrated at a commercial scale.
Titanium dioxide produced by the WRP technology has the following advantages:
- High efficiency plant with lowest production costs
- Green/Clean technology compared to other processes
- Less Capital intensive than competing technologies
- Particle size control for different market applications
The intellectual properties available for licensing include:
- US Patent # 6,375,923 “PROCESSING TITANIFEROUS ORE TO TITANIUM DIOXIDE PIGMENT”.
- US Patent # 6,440,383 “PROCESSING AQUEOUS TITANIUM CHLORIDE SOLUTIONS TO ULTRAFINE TITANIUM DIOXIDE”.
- US Patent # 6,548,039 “PROCESSING AQUEOUS TITANIUM SOLUTION TO TITANIUM DIOXIDE PIGMENT”.
- US Patent # 7,407,690 “PROCESS FOR SURFACE MODIFICATIONS OF TiO2 PARTICLES AND OTHER CERAMIC MATERIALS”.
- US Patent # 7,482,304 “METHOD FOR PRODUCING STRUCTURES”.
- Trade secrets in Spray Hydrolysis to produce the right particle size
- Know how to produce high quality TiO2: a) digestion of ilmenite ore; b) crystallization;
c) Experimental design to optimize the manufacturing process - Engineering drawings for pilot plant process
- Ability to produce high quality TiO2 with reduced pollution
- High profit margins from using cheap ilmenite ore
- Licensing will include an off take purchase agreement worth $800 million
Company News
